Curcumin Negatively Regulates Cigarette Smoke-Induced Renal Cell Carcinoma Epithelial-Mesenchymal Transition Through

Tao Zhang1, Li Zhao2, Taotao Zhang1

  • 1Department of Urologic Surgery, The Second Affiliated Hospital of Anhui Medical University, Hefei 230032, People's Republic of China.

Oncotargets and Therapy
|October 16, 2020
PubMed
Abstract

Insights

Cigarette smoke promotes renal cell carcinoma (RCC) by activating the ERK5/AP-1 pathway, driving epithelial-mesenchymal transition (EMT). Curcumin and XMD8-92 inhibit this process, offering potential therapeutic strategies for smoking-associated kidney cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Renal cell carcinoma (RCC) development mechanisms at the molecular level are under-researched.
  • Epithelial-mesenchymal transition (EMT) is crucial in tumor genesis and progression, often involving mitogen-activated protein kinase (MAPK) pathways.
  • This study investigates the role of the ERK5/AP-1 pathway in EMT-driven RCC progression.

Purpose of the Study:

  • To elucidate the molecular mechanisms linking cigarette smoke exposure to renal cell carcinoma (RCC) progression.
  • To investigate the role of epithelial-mesenchymal transition (EMT) and the ERK5/AP-1 pathway in cigarette smoke-induced RCC.
  • To evaluate the potential of curcumin as an intervention for smoking-associated RCC.

Main Methods:

  • Utilized RCC cell lines exposed to cigarette smoke extract (CSE) in vitro.
  • Employed immunohistochemistry (IHC), Western blotting, and real-time quantitative reverse transcription PCR.
  • Assessed EMT by analyzing cell morphology, invasion, migration, and epithelial/mesenchymal marker expression.

Main Results:

  • Down-regulation of E-cadherin and up-regulation of Vimentin, N-cadherin, and TWIST in smoking-associated RCC tissues.
  • Cigarette smoke extract (CSE) activates the ERK5/AP-1 pathway, promoting RCC EMT.
  • ERK5 inhibition (XMD8-92) or curcumin treatment reversed CSE-induced EMT by inhibiting the ERK5/AP-1 pathway.

Conclusions:

  • The ERK5/AP-1 signaling pathway is vital in cigarette smoke-associated RCC development.
  • Inhibition of the ERK5/AP-1 pathway represents a potential therapeutic strategy for smoking-related kidney cancer.
  • Curcumin demonstrates efficacy in reversing CSE-induced EMT via the ERK5/AP-1 pathway.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.4K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K